Teijin Limited - TINLY

TINLY Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
TINLY	-3.4	-3.4	-4.2	-15.7	-9.7	-8.9	-36.4	-55.7	-40.3	-66.1
S&P 500	1.0	1.5	1.1	2.3	8.9	23.6	33.8	80.6	196.5	33856.2

Compare TINLY with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	TINLY
name	Teijin Limited
price	8.14
changes percentage	-3.4401
change	-0.29
day low	8.14
day high	8.43
year high	10.32
year low	7.57
market cap	1568382632
price avg 50	8.5286
price avg 200	9.12065
exchange	PNK
volume	400
avg volume	268
open	8.43
previous close	None
eps	-1.32
pe	-6.17
earnings announcement	2025-02-06T06:00:00.000+0000
shares outstanding	192675999
timestamp	2025-01-17 20:00:00

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 67.3%

Overall Quarterly Financial Health: 37.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000000000
revenue	1032773000000	1018751000000	1.38
gross profit	275773000000	218764000000	26.06
gross profit ratio	0.27	0.21	24.35
research and development expenses	42560000000	31935000000	33.27
operating expenses	262231000000	205901000000	27.36
interest income	2630000000	1262000000	108.40
interest expense	10782000000	7084000000	52.20
ebitda	118078000000	91630000000	28.86
ebitdaratio	0.11	0.09	27.11
operating income	13542000000	12863000000	5.28
operating income ratio	0.01	0.01	3.85
net income	10599000000	-17695000000	159.90
net income ratio	0.01	-0.02	159.09
eps	55	-92.04	159.76

Overall Score of Annual Income Statement

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 1,032,773 million in 2024 from 1,018,751 million in 2023 representing a change of 1.38%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 275,773 million in 2024 from 218,764 million in 2023 representing a change of 26.06%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 42,560 million in 2024 from 31,935 million in 2023 representing a change of 33.27%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Income: Operating income increased to 13,542 million in 2024 from 12,863 million in 2023 representing a change of 5.28%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 10,599 million in 2024 from -17,695 million in 2023 representing a change of 159.9%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 55 in 2024 from 55 in 2023 representing a change of 159.76%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 262,231 million in 2024 from 205,901 million in 2023 representing a change of 27.36%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 118,078 million in 2024 from 91,630 million in 2023 representing a change of 28.86%. The decrease in EBITDA indicates declined operational efficiency and profitability.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2025Q1	2024Q4	Q/Q change %
0000000000
revenue	255341000000	273174000000	-6.53
gross profit	63448000000	75522000000	-15.99
gross profit ratio	0.25	0.28	-10.12
research and development expenses	0	8900000000	-100.00
operating expenses	55407000000	66837000000	-17.10
interest income	1937000000	721000000	168.65
interest expense	3506000000	1449000000	141.96
ebitda	27352000000	19155000000	42.79
ebitdaratio	0.11	0.11	-2.68
operating income	8041000000	8685000000	-7.42
operating income ratio	0.03	0.03	-0.95
net income	4451000000	7147000000	-37.72
net income ratio	0.02	0.03	-33.37
eps	15.93	37.12	-57.09

Overall Score of Quarterly Income Statement

0.25 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 255,341 million in 2025Q1 from 273,174 million in 2024Q4 representing a change of -6.53%. This indicates a sales shrinking, which is a negative sign for the company.

  Gross Profit: Gross Profit decreased to 63,448 million in 2025Q1 from 75,522 million in 2024Q4 representing a change of -15.99%. This indicates a sales profitability decline, which is a negative sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses decreased to 0 million in 2025Q1 from 8,900 million in 2024Q4 representing a change of -100.0%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Income: Operating income decreased to 8,041 million in 2025Q1 from 8,685 million in 2024Q4 representing a change of -7.42%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to 4,451 million in 2025Q1 from 7,147 million in 2024Q4 representing a change of -37.72%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 15.93 in 2025Q1 from 15.93 in 2024Q4 representing a change of -57.09%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• 📈 Positive Indicators

  Operating Expenses: Operating Expenses decreased to 55,407 million in 2025Q1 from 66,837 million in 2024Q4 representing a change of -17.1%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 27,352 million in 2025Q1 from 19,155 million in 2024Q4 representing a change of 42.79%. The increase in EBITDA indicates improved operational efficiency and profitability.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000000000
total assets	1251021000000	1272457000000	-1.68
total liabilities	769087000000	821373000000	-6.37
total equity	481934000000	451084000000	6.84
cash and cash equivalents	125921000000	140307000000	-10.25
short term investments	2360000000	2473000000	-4.57
long term investments	81316000000	96795000000	-15.99
total current assets	623504000000	613341000000	1.66
total non current assets	627519000000	659116000000	-4.79
total current liabilities	424682000000	414836000000	2.37
total non current liabilities	344405000000	406537000000	-15.28
common stock	71833000000	71833000000	0.00
retained earnings	219062000000	213923000000	2.40
total debt	495723000000	529418000000	-6.36

Overall Score of Annual Balance Sheet

0.56 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 1,251,021 million in 2024 from 1,272,457 million in 2023 representing a change of -1.68%. Suggesting a decrease in asset holdings.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 125,921 million in 2024 from 140,307 million in 2023 representing a change of -10.25%. This indicates a decrease in available liquid assets.

  Short Term Investments: Short Term Investments decreased to 2,360 million in 2024 from 2,473 million in 2023 representing a change of -4.57%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 424,682 million in 2024 from 414,836 million in 2023 representing a change of 2.37%. This indicates a higher short-term debt burden.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 769,087 million in 2024 from 821,373 million in 2023 representing a change of -6.37%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 481,934 million in 2024 from 451,084 million in 2023 representing a change of 6.84%. This indicates an increase in shareholders' equity.

  Total Current Assets: Total Current Assets increased to 623,504 million in 2024 from 613,341 million in 2023 representing a change of 1.66%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 219,062 million in 2024 from 213,923 million in 2023 representing a change of 2.4%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 495,723 million in 2024 from 529,418 million in 2023 representing a change of -6.36%. This indicates a reduction in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2025Q1	2024Q4	Q/Q change %
0000000000
total assets	1289137000000	1282456000000	0.52
total liabilities	835513000000	800523000000	4.37
total equity	453624000000	481933000000	-5.87
cash and cash equivalents	126109000000	123561000000	2.06
short term investments	14919000000	2360000000	532.16
long term investments	86446000000	81316000000	6.31
total current assets	697530000000	623504000000	11.87
total non current assets	591607000000	658952000000	-10.22
total current liabilities	481762000000	424682000000	13.44
total non current liabilities	353751000000	375841000000	-5.88
common stock	71833000000	71833000000	0.00
retained earnings	205690000000	219062000000	-6.10
total debt	574044000000	498875000000	15.07

Overall Score of Quarterly Balance Sheet

0.44 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 1,289,137 million in 2025Q1 from 1,282,456 million in 2024Q4 representing a change of 0.52%. Suggesting a growth in asset holdings.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 126,109 million in 2025Q1 from 123,561 million in 2024Q4 representing a change of 2.06%. This indicates an increase in available liquid assets.

  Short Term Investments: Short Term Investments increased to 14,919 million in 2025Q1 from 2,360 million in 2024Q4 representing a change of 532.16%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 697,530 million in 2025Q1 from 623,504 million in 2024Q4 representing a change of 11.87%. This indicates a better liquidity position.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 835,513 million in 2025Q1 from 800,523 million in 2024Q4 representing a change of 4.37%. This indicates an increase in overall liabilities.

  Total Equity: Total Equity decreased to 453,624 million in 2025Q1 from 481,933 million in 2024Q4 representing a change of -5.87%. This indicates a decrease in shareholders' equity.

  Total Current Liabilities: Total Current Liabilities increased to 481,762 million in 2025Q1 from 424,682 million in 2024Q4 representing a change of 13.44%. This indicates a higher short-term debt burden.

  Retained Earnings: Retained Earnings decreased to 205,690 million in 2025Q1 from 219,062 million in 2024Q4 representing a change of -6.1%. This indicates an accumulated losses.

  Total Debt: Total Debt increased to 574,044 million in 2025Q1 from 498,875 million in 2024Q4 representing a change of 15.07%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000000000
net change in cash	-16745000000	9611000000	-274.23
operating cash flow	69451000000	55086000000	26.08
free cash flow	4409000000	-2650000000	266.38
capital expenditure	-65042000000	-57736000000	-12.65
depreciation and amortization	78885000000	78767000000	0.15
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts payables	-11187000000	-3055000000	-266.19
inventory	-21611000000	-26548000000	18.60
acquisitions net	-782000000	5233000000	-114.94
investments in property plant and equipment	-58112000000	-57736000000	-0.65
net cash used for investing activites	-46052000000	-52427000000	12.16
debt repayment	-33677000000	4350000000	-874.18
common stock issued	0	0	NaN
common stock repurchased	-15000000	-5000000	-200.00
dividends paid	-5292000000	-10571000000	49.94
net cash used provided by financing activities	-43159000000	7180000000	-701.10
cash at end of period	123562000000	140307000000	-11.93
accounts receivables	-6510000000	16528000000	-139.39
cash at beginning of period	140307000000	130696000000	7.35

Overall Score of Annual Cashflow Statement

0.71 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -16,745 million in 2024 from 9,611 million in 2023 representing a change of -274.23%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Accounts Payables: The absolute value of Accounts Payables increased to 11,187 million in 2024 from 3,055 million in 2023 representing a change of -266.19%. This indicates that the company has increased its outstanding obligations to its suppliers.

• 📈 Positive Indicators

  Operating Cash Flow: Operating Cash Flow increased to 69,451 million in 2024 from 55,086 million in 2023 representing a change of 26.08%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 4,409 million in 2024 from -2,650 million in 2023 representing a change of 266.38%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -65,042 million in 2024 from -57,736 million in 2023 representing a change of -12.65%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Receivables: Accounts Receivables decreased to -6,510 million in 2024 from 16,528 million in 2023 representing a change of -139.39%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

  Dividends Paid: Dividends Paid increased to -5,292 million in 2024 from -10,571 million in 2023 representing a change of 49.94%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2025Q1	2024Q4	Q/Q change %
0000000000
operating cash flow	8631000000	0	NaN
free cash flow	-5803000000	0	NaN
capital expenditure	-14434000000	0	NaN
depreciation and amortization	19311000000	0	NaN
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts receivables	10592000000	0	NaN
accounts payables	-11254000000	0	NaN
inventory	-12160000000	0	NaN
acquisitions net	533000000	0	NaN
investments in property plant and equipment	-14434000000	0	NaN
net cash used for investing activites	-17055000000	0	NaN
debt repayment	-2012000000	0	NaN
common stock issued	0	0	NaN
common stock repurchased	-2000000	0	NaN
dividends paid	-2888000000	0	NaN
net cash used provided by financing activities	44364000000	0	NaN
net change in cash	126109000000	0	NaN
cash at end of period	126109000000	0	NaN
cash at beginning of period	0	0	NaN

Overall Score of Quarterly Cashflow Statement

0.43 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 126,109 million in 2025Q1 from 0 million in 2024Q4 representing a change of nan%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 8,631 million in 2025Q1 from 0 million in 2024Q4 representing a change of nan%. This indicates that the company generated more cash from its core business operations.

  Capital Expenditure: Capital Expenditure decreased to -14,434 million in 2025Q1 from 0 million in 2024Q4 representing a change of nan%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

• 📉 Negative Indicators

  Free Cash Flow: Free Cash Flow decreased to -5,803 million in 2025Q1 from 0 million in 2024Q4 representing a change of nan%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Accounts Payables: The absolute value of Accounts Payables increased to 11,254 million in 2025Q1 from 0 million in 2024Q4 representing a change of nan%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables increased to 10,592 in 2025Q1 from 0 million in 2024Q4 representing a change of nan%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -2,888 million in 2025Q1 from 0 million in 2024Q4 representing a change of nan%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2024-03-31	2023-03-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	5366.05	5299.29	1.26
net income per share	55.07	-92.04	159.83
operating cash flow per share	360.85	286.54	25.93
free cash flow per share	22.91	-13.78	266.19
cash per share	559.64	579.4	-3.41
book value per share	2504.01	2346.43	6.72
tangible book value per share	1749.13	1511.29	15.74
shareholders equity per share	2361.92	2214.2	6.67
interest debt per share	2631.69	2773.81	-5.12
market cap	271085736964.5	268371228000	1.01
enterprise value	640887736964.5	651753228000	-1.67
pe ratio	25.58	-15.17	268.64
price to sales ratio	0.26	0.26	-0.36
pocfratio	3.9	4.87	-19.88
pfcf ratio	61.48	-101.27	160.71
pb ratio	0.6	0.63	-5.41
ptb ratio	0.6	0.63	-5.41
ev to sales	0.62	0.64	-3.00
enterprise value over ebitda	5.43	7.73	-29.75
ev to operating cash flow	9.23	11.83	-22.01
ev to free cash flow	145.36	-245.94	159.10
earnings yield	0.04	-0.07	159.30
free cash flow yield	0.02	-0.01	264.71
debt to equity	1.09	1.24	-11.78
debt to assets	0.4	0.42	-6.43
net debt to ebitda	3.13	4.54	-31.09
current ratio	1.47	1.48	-0.70
interest coverage	1.26	1.82	-30.83
income quality	6.55	-36.97	117.72
dividend yield	0.02	0.04	-50.44
payout ratio	0.5	-0.6	183.58
sales general and administrative to revenue	0.15	0.13	9.12
research and ddevelopement to revenue	0.04	0.03	31.46
intangibles to total assets	0.12	0.13	-10.13
capex to operating cash flow	0.94	1.05	-10.65
capex to revenue	0.06	0.06	11.12
capex to depreciation	0.82	0.77	6.99
stock based compensation to revenue	0	0	NaN
graham number	1710.73	2141.41	-20.11
roic	0.01	0.14	-95.38
return on tangible assets	0.01	-0.02	158.61
graham net net	-2057.32	-2311.06	10.98
working capital	198822000000	198505000000	0.16
tangible asset value	336645000000	290534000000	15.87
net current asset value	-145585000000	-178008000000	18.21
invested capital	714138000000	706912000000	1.02
average receivables	191434000000	186999500000	2.37
average payables	101740000000	102112000000	-0.36
average inventory	213944500000	180673000000	18.42
days sales outstanding	70.61	65.6	7.64
days payables outstanding	48.43	48.81	-0.77
days of inventory on hand	111.46	93.18	19.62
receivables turnover	5.17	5.56	-7.10
payables turnover	7.54	7.48	0.78
inventory turnover	3.27	3.92	-16.40
roe	0.02	-0.04	156.09
capex per share	337.94	300.33	12.52

• Negative

  ROE: Return on Equity (ROE) increased to 0.02 on 2024-03-31 from -0.04 on 2023-03-31, representing a change of 156.09%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 25.58 on 2024-03-31 from -15.17 on 2023-03-31, representing a change of 268.64%. Indicating an increase in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 1.47 on 2024-03-31 from 1.48 on 2023-03-31, representing a change of -0.70%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

• Debt-to-Equity Ratio:

• Quarterly Financial Ratios

	2024-06-30 Q1	2024-03-31 Q4	Q/Q change %
TINLY
calendar year	2024	2023	NaN
revenue per share	1326.08	1415.89	-6.34
net income per share	23.12	37.04	-37.60
operating cash flow per share	44.82	0	NaN
free cash flow per share	-30.14	0	NaN
cash per share	732.41	664.89	10.15
book value per share	2355.84	2497.91	-5.69
tangible book value per share	1606.67	1744.87	-7.92
shareholders equity per share	2213.26	2356.16	-6.07
interest debt per share	2999.43	2576.89	16.40
market cap	257828856649	271748351704.5	-5.12
enterprise value	705763856649	641550351704.5	10.01
pe ratio	14.48	9.51	52.35
price to sales ratio	1.01	0.99	1.50
pocfratio	29.87	0	NaN
pfcf ratio	-44.43	0	NaN
pb ratio	0.6	0.6	1.20
ptb ratio	0.6	0.6	1.20
ev to sales	2.76	2.35	17.69
enterprise value over ebitda	25.8	16.62	55.29
ev to operating cash flow	81.77	0	NaN
ev to free cash flow	-121.62	0	NaN
earnings yield	0.02	0.03	-34.36
free cash flow yield	-0.02	0	NaN
debt to equity	1.35	1.09	23.52
debt to assets	0.45	0.4	12.38
net debt to ebitda	16.38	9.58	70.98
current ratio	1.45	1.47	-1.38
interest coverage	2.29	5.99	-61.74
income quality	1.94	0	NaN
dividend yield	0.01	0	NaN
payout ratio	0.65	0	NaN
sales general and administrative to revenue	0	0.25	-100.00
research and ddevelopement to revenue	0	0.03	-100.00
intangibles to total assets	0.11	0.12	-3.65
capex to operating cash flow	1.67	0	NaN
capex to revenue	0.06	0	NaN
capex to depreciation	0.75	0	NaN
stock based compensation to revenue	0	0	NaN
graham number	1072.9	1401.36	-23.44
roic	0.0	0.0	-2.70
return on tangible assets	0.0	0.01	-39.85
graham net net	-2128.77	-1945.68	-9.41
working capital	215768000000	198822000000	8.52
tangible asset value	309370000000	336646000000	-8.10
net current asset value	-137983000000	-145584000000	5.22
invested capital	699124000000	714138000000	-2.10
average receivables	205129000000	191017000000	7.39
average payables	116768000000	96324500000	21.22
average inventory	242308000000	229035000000	5.80
days sales outstanding	74.19	65.82	12.71
days payables outstanding	62.42	45.73	36.49
days of inventory on hand	118.87	105.26	12.93
receivables turnover	1.21	1.37	-11.28
payables turnover	1.44	1.97	-26.74
inventory turnover	0.76	0.86	-11.45
roe	0.01	0.02	-33.57
capex per share	74.96	0	NaN

• Negative

  ROE: Return on Equity (ROE) decreased to 0.01 on 2024-06-30 Q1 from 0.02 on 2024-03-31 Q4, representing a change of -33.57%. Suggesting that the company has not been generating high returns for its shareholders.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 14.48 on 2024-06-30 Q1 from 9.51 on 2024-03-31 Q4, representing a change of 52.35%. Indicating an increase in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 1.45 on 2024-06-30 Q1 from 1.47 on 2024-03-31 Q4, representing a change of -1.38%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

• Debt-to-Equity Ratio:

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

None